Back to today’s briefing

Story perspectives

Breakthrough 'Disease-on-a-Chip' Model Advances ALS Research

7/20/2025

22 2

Summary

Story summary

Researchers at Cedars-Sinai have unveiled a groundbreaking "disease-on-a-chip" model for amyotrophic lateral sclerosis (ALS) using stem cells. This innovative approach simulates the early stages of ALS, uncovering abnormal glutamate signaling in motor neurons. By providing a new avenue for drug testing and insights into disease progression, it holds promise for improving treatment strategies.

1 of 1

Story summary

Researchers at Cedars-Sinai have unveiled a groundbreaking "disease-on-a-chip" model for amyotrophic lateral sclerosis (ALS) using stem cells. This innovative approach simulates the early stages of ALS, uncovering abnormal glutamate signaling in motor neurons. By providing a new avenue for drug testing and insights into disease progression, it holds promise for improving treatment strategies.